The full side-by-side
Every provider, every dimension
| Provider | Score | Semaglutide | Tirzepatide | Membership | Pharmacy | Clinical model | States | Guarantee |
|---|---|---|---|---|---|---|---|---|
MLMaxLife #1 |
9.2 | $175/mo$135 (12-mo) |
$195/mo$150 (12-mo) |
$0 | ✓ Named | Licensed clinician | All 50 | ✓ Money-back |
MoMochi Health | 7.6 | $99/mo | $199/mo | + $79/mo | Not named | Video + dietitian | 50 + DC | Restrictive |
TrTrimRx | 7.3 | $199/mo$174 (12-mo) | $349/mo$283 (12-mo) | $0 | Not named | Async | All 50* | ✓ Results |
EdEden | 7.1 | $229/mo$149 1st mo | $329/mo | $0 | Not named | Async, no labs | Broad* | Verify |
ivIvim Health | 6.9 | from $7512-mo | from $13312-mo | + $75/mo | Not named | Titrated dosing | Broad* | Verify |
HHenry Meds | 6.8 | inj $297+oral $249 | oral $349+ | $0 | ✓ Hallandale | Video or async | ~45 | Non-refundable |
ZZealthy | 6.6 | $151/mo3-mo | $216/mo3-mo | + $135/mo | Not named | Providers + coaches | Broad* | Verify |
WWillow | 6.4 | $299/mo | $299–549by dose | $0 | Not named | Async | ~33* | Verify |
FeFella Health | 6.2 | $299/mo$99 (12-mo) | $399/mo$199 (12-mo) | $0 | Not named | Men-focused | Broad* | Verify |
EmEmerge | 6.0 | Not offeredtirz-only | $287–419by dose | $0 | ✓ Named | Async | 49 (excl. CA) | Verify |
Scores follow our published rubric. Prices are advertised medication cost; a Membership entry means a separate recurring fee applies on top. * State coverage marked "Broad" or "All 50*" is a provider marketing claim we could not fully verify. Figures sourced June 2026 and change frequently — verify on each provider's own site. Read the full provider reviews for detail and sources.
MaxLife vs. the field: head-to-head
MaxLife vs. Mochi Health
Mochi wins on clinical depth (live video plus a dietitian) and review volume (~15.6k). MaxLife wins on cost predictability and sourcing: one flat price with no membership, versus Mochi's $99 medication plus a separate ~$79/mo membership, and MaxLife names its pharmacy while Mochi does not. Choose Mochi for hands-on clinical support; choose MaxLife for a lower, predictable all-in cost. See the Mochi review.
MaxLife vs. Henry Meds
Both name a pharmacy and skip a membership fee. Henry Meds offers oral and sublingual formats and low entry pricing, but its real prices are gated behind an intake quiz with a $100/mo dose upcharge, its BBB rating is an F with 100% complaint non-response, and its Trustpilot listing has been flagged for suspected incentivized reviews. MaxLife publishes flat pricing up front and carries a clean regulatory record. See the Henry Meds review.
MaxLife vs. TrimRx
TrimRx is the closest structural match: flat all-in pricing, no membership, and a results guarantee. The differences are sourcing and reviews: MaxLife names its pharmacy and holds a 4.4 Trustpilot score, while TrimRx does not name its pharmacy and sits nearer 3.4 with polarized feedback. TrimRx's tirzepatide also runs higher ($349 vs $195). See the TrimRx review.
Comparison FAQ
Which compounded GLP-1 provider is cheapest?
On advertised medication sticker price, Ivim (semaglutide from about $75/mo on a 12-month plan) and Mochi ($99/mo semaglutide) are lowest, but both add a separate monthly membership on top of the medication. On flat all-in pricing with no membership, MaxLife is $175/mo for semaglutide ($135/mo on a 12-month plan). Verify current pricing on each provider's own site.
Which providers name their compounding pharmacy?
MaxLife names its licensed U.S. pharmacy partners, Henry Meds names Hallandale Pharmacy, and Emerge names partner pharmacies including Empower, Hallandale, Strive, and Alchemist. Mochi, TrimRx, Eden, Ivim, Zealthy, Willow, and Fella do not publicly name their current compounding pharmacy. Because compounded drugs are not FDA-approved, the pharmacy is the primary quality signal.
Is compounded GLP-1 FDA-approved?
No. Compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. They are prepared by U.S.-licensed compounding pharmacies when a licensed provider determines treatment is appropriate. Compounded semaglutide is not Ozempic® or Wegovy®; compounded tirzepatide is not Mounjaro® or Zepbound®.